Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Intermediate filaments
  • Track 1-2Mechanotransduction
  • Track 1-3Dynamics of focal adhesions and invadosomes
  • Track 1-4Signaling networks governing cell migration
  • Track 1-5Chemotaxis and directed cell migration
  • Track 1-6Cytoskeleton-membrane interactions including actin and microtubule cytoskeleton
  • Track 1-7Cilia & Flagella and Molecular Motors
  • Track 2-1Cell-matrix and cell-cell interactions
  • Track 2-2Membrane trafficking
  • Track 2-3Organelles and membrane biology
  • Track 2-4Nuclear structure and function
  • Track 2-5Regulation and organization of the genome
  • Track 2-6Cell Division: Mitosis & meiosis and cell polarity
  • Track 2-7Signal transduction and signaling networks proteostasis
  • Track 2-8Cell Stress, and aging
  • Track 2-9Development and Morphogenesis
  • Track 2-10Cell Biology of the Neuron
  • Track 2-11Prokaryotic, protists and parasites cell biology
  • Track 2-12Host-pathogen/host-commensal interactions
  • Track 3-1Advances in cell sciences and tissue engineering
  • Track 3-2Cell Line Development for novel molecules
  • Track 3-3The role of genetic and epigenetic factors in development
  • Track 3-4Organ-specific cancers, cancer genetics, drug development and diagnostic
  • Track 3-5Advances in cell and gene therapy
  • Track 3-6Market wide and global applications
  • Track 3-7Medical Diagnosis and repair
  • Track 3-8Molecular biology of the cell
  • Track 3-9Physical, Chemical & Systems Cell Biology
  • Track 3-10Biomaterials in tissue engineering
  • Track 4-1Nano particles interacting with living organisms
  • Track 4-2Treatment of tumor by hyperthermia
  • Track 4-3Diagnosis and monitoring of cancer by nanotechnology
  • Track 4-4Neutron capture therapy of cancer by nanoparticles
  • Track 4-5Dendritic nano structures for cancer therapy
  • Track 4-6Nano patterned surfaces for stem cell engineering
  • Track 4-7Control of mesenchymal stem cell fate by engineering the nano environment
  • Track 4-8Expansion of stem cells by nano tissue engineering
  • Track 4-9In vivo tracking: Pre-clinical and clinical studies
  • Track 4-10Imaging methods and technologies
  • Track 5-1Size Regulation and Signaling Pathways
  • Track 5-2Genetics of Growth and Regeneration and Morphological Variation
  • Track 5-3Cellular senescence and immortalization
  • Track 5-4Signal transduction and integration of regulatory information
  • Track 5-5Gene expression and gene regulatory mechanisms
  • Track 5-6Differentiation, development and programmed cell death
  • Track 5-7Epigenetics in Growth and Regeneration
  • Track 6-1Types of stem cell and stem cell therapy
  • Track 6-2Stem cell Banking
  • Track 6-3Stem cell biomarkers and novel approaches in stem cell technologies
  • Track 6-4Cellular plasticity and reprogramming
  • Track 6-5Cell and Organ Regeneration
  • Track 6-6Stem Cells Growth Development And Regeneration
  • Track 7-1Primordial germ cells, sertolicells and gonocytes
  • Track 7-2Regulation of proliferation and differentiation of primordial germ cells
  • Track 7-3Cell- cell interactions
  • Track 7-4Germline stem cell populations maintained by instructions from a local niche.
  • Track 7-5Invivo and Invitro Stem cell Microenvironment
  • Track 7-6Vertebrate Adult Stem cell Niche
  • Track 7-7Extracellular Matrix Mimicking strategies for Stem cell Niche
  • Track 7-8Cancer Stem Cell Niche
  • Track 8-1Biologic and molecular basis of regenerative medicine
  • Track 8-2Fundamental molecular and genetic errors of disease
  • Track 8-3The molecular basis pluripotency in principles of regenerative medicine
  • Track 8-4Somatic cloning and epigenetic reprogramming in mammals
  • Track 8-5Regenerative medicine for disease of the retina
  • Track 8-6Gene chips in regenerative medicine
  • Track 8-7Genes to personalized medicine
  • Track 8-8Regeneration technologies for hearts, limbs and other organs
  • Track 8-9Bone regeneration and modern techniques
  • Track 8-10Cartilage regeneration
  • Track 8-11Graft vs host disease and crohn’s disease
  • Track 9-1Software tools for systems biology-Squard,cnetanalyser,biotapestry,sbml-saT
  • Track 9-2Properties that make a molecule a good drug
  • Track 9-3Quantum mechanics in drug design
  • Track 9-4Molecular mechanics –protein folding ,docking
  • Track 9-5Cheminformatics
  • Track 9-6Gene expression analysis
  • Track 9-7Bioinformatics analysis of stem cells
  • Track 9-8Cellular computing and drug discovery
  • Track 9-9Biorobotics and biosensors
  • Track 10-1Cell Transplantation And Intercellular Trafficking
  • Track 10-2Cell therapy in cosmetology
  • Track 10-3Injured skin therapy
  • Track 10-4Mechanism of transduction by cell receptor proteins
  • Track 10-5Target cell adaptation
  • Track 10-6Cell signaling pathways
  • Track 10-7Cellular oncogenes
  • Track 10-8Molecular signaling and cellular communication
  • Track 10-9Signal Transduction
  • Track 11-1Improved cell culture System
  • Track 11-2Modified cell growth and differentiation
  • Track 11-3Transplantation of engineered cells and tissues
  • Track 11-4Stem Cell Technology in Placental Care
  • Track 11-5Stem Cells in Transplantations
  • Track 11-6Somatic Cell Nuclear Transfer
  • Track 11-7Immunomodulation
  • Track 11-8Cardiac tissue engineering
  • Track 11-9Tissue engineered food
  • Track 12-1Tissue aging
  • Track 12-2Antiaging therapies
  • Track 12-3Mitochondrial dysfunction
  • Track 12-4Novel therapeutics
  • Track 12-5Cutaneous Regeneration
  • Track 12-6Cellular plasticity and reprogramming
  • Track 12-7Cell differentiation and disease modeling
  • Track 12-8Stem cell apoptosis and signal transduction
  • Track 13-1Novel Stem Cell Technologies
  • Track 13-2Efficient cell/dna Delivery and microencapsulation techniques
  • Track 13-3Cancer therapy
  • Track 13-4Rheumatoid arthritis and Spinal cord injury
  • Track 13-5Parkinson’s disease
  • Track 13-6Severe burns and diabetes
  • Track 13-7Imaging technologies, single molecule imaging, and super-resolution
  • Track 13-8Proteomics and genomic methods
  • Track 13-9New technologies for cell biology
  • Track 13-10Normal and diseased organs and therapeutics
  • Track 14-1Stem cells in tissue engineering
  • Track 14-2Translating stem cell research into clinical medicine: FDA approved clinical trials
  • Track 14-3Bone marrow transplantation to treat cancer and other diseases
  • Track 14-4Stem cell therapy for type I diabetes
  • Track 14-5Generation of pancreatic islets from stem cells
  • Track 14-6Promoting endogenous stem cell proliferation in the treatment of depression
  • Track 14-7Stem cells will offer revolutionary therapeutics for regenerative medicine
  • Track 15-1Cancer stem cells
  • Track 15-2Oncogenes and tumor suppressors
  • Track 15-3Tumor invasion and metastasis
  • Track 15-4Tumor microenvironment
  • Track 15-5Cancer therapy
  • Track 16-1The ethics and politics of stem cell research
  • Track 16-2Bioethics & IPR
  • Track 16-3Biosafety and rDNA Guidelines